Major Depressive Disorder and Treatment-Resistant Depression are the most well-studied TMS indications. TMS stimulates the left dorsolateral prefrontal cortex to reactivate underactive mood-regulating circuits.
50-60% response rate • 30-35% full remission in TRD patients
Generalized anxiety, panic disorder, and anxious depression respond to TMS protocols targeting overactive fear-processing regions, calming hyperarousal and reducing chronic anxiety without sedating medications.
FDA-cleared for anxious depression • Significant GAD-7 score reductions
Emerging research supports TMS for anorexia nervosa and binge-eating disorder by modulating food-reward circuitry and reducing compulsive thought patterns tied to disordered eating behaviors.
Off-label protocol • Targets prefrontal & reward pathways
TMS is used adjunctively for bipolar depression, offering a nonpharmacological option during depressive episodes with careful protocol selection to avoid mood destabilization.
Off-label • Adjunct to mood stabilizers • Reduces depressive episodes
Non-invasive - no surgery, no anesthesia required
FDA-cleared for depression, OCD, anxious depression, and smoking cessation
Off-label protocols for neurological conditions
Patients resume normal activities immediately after treatment
What is TMS Case Studies Pricing Research
Advanced Neuromodulation Therapy
Accelerated Transcranial Magmentic Stimulation (TMS) for mentla health and neurological conditions - 20 Targeted treatments in a SINGLE day.
For Mental Health
Restoring Balance in Mental Health
TMS directly targets the brain circuits underlying these conditions - without medication side effects.
"I've tried many options over the years and I am so glad I found TMS treatment for my son's depression. A real gamer changer!"
- Cheryl A Colleyville TX.
